Related Experiment Videos

Intermittent claudication. An update on management

P A Blombery1

  • 1Vascular Laboratory, Alfred Hospital, Prahran, Melbourne.

Drugs
|September 1, 1987
PubMed

Insights

The primary treatment for claudication involves addressing risk factors like smoking and using antiplatelet drugs. Comprehensive management targets systemic atherosclerosis for improved long-term outcomes and lifespan.

Area of Science:

  • Vascular Medicine
  • Cardiovascular Disease Management

Background:

  • Claudication is often linked to widespread atherosclerosis, impacting overall lifespan.
  • Effective management requires addressing systemic vascular disease, not just leg symptoms.

Purpose of the Study:

  • To outline current treatment strategies for claudication.
  • To emphasize the importance of holistic management of atherosclerosis.

Main Methods:

  • Review of established risk factor modification (smoking cessation).
  • Discussion of pharmacologic interventions (antiplatelet agents, pentoxifylline).
  • Evaluation of interventional procedures (angioplasty, vascular reconstruction).

Main Results:

  • Risk factor reversal and antiplatelet therapy are foundational.
  • Systemic atherosclerotic disease significantly affects prognosis.
  • Interventional procedures offer symptomatic relief with low risk for disabled patients.

Conclusions:

  • Claudication treatment necessitates a comprehensive approach to atherosclerosis.
  • Lifestyle changes and medication are key, supplemented by interventions when needed.
  • Holistic management improves long-term survival and quality of life.

Related Concept Videos